WPG Advisers
JAZZ icon

WPG Advisers’s Jazz Pharmaceuticals JAZZ Stock Holding History

WPG Advisers’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$87.1K Sell
376
-8
-2% -$1.98K 0.05% 210
2026
Q2 		$92.5K Buy
384
+44
+13% +$9.6K 0.05% 200
2026
Q1 		$64.3K Sell
340
-14
-4% -$2.45K 0.05% 226
2025
Q4 		$60.2K Sell
354
-11
-3% -$1.69K 0.04% 255
2025
Q3 		$48.1K Buy
365
+30
+9% +$3.6K 0.04% 299
2025
Q2 		$35.6K Buy
335
+275
+458% +$29.9K 0.03% 354
2025
Q1 		$7.45K Buy
60
+37
+161% +$4.83K 0.01% 737
2024
Q4 		$2.83K Buy
+23
New +$2.71K ﹤0.01% 997

Other funds holding JAZZ

LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Boston Trust Walden
Boston Trust Walden Boston, Massachusetts $12.4B AUM 21.62% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Polaris Capital Management
Polaris Capital Management Boston, Massachusetts $953M AUM 27.74% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

WPG Advisers's JAZZ Position: Q3 2026 in Review

WPG Advisers reduced its Jazz Pharmaceuticals (JAZZ) stake by 2.1% in Q3 2026, selling an estimated $1.98K and leaving 376 shares worth $87.1K. The position accounts for 0.05% of the portfolio, ranked #210.

WPG Advisers first reported a position in JAZZ in Q4 2024 and has held it in 8 quarters since. The position peaked at $92.5K in Q2 2026. 331 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.

  • WPG Advisers held 376 shares of Jazz Pharmaceuticals worth $87.1K as of Q3 2026.
  • WPG Advisers sold 8 Jazz Pharmaceuticals shares in Q3 2026, an estimated $1.98K.
  • Jazz Pharmaceuticals made up 0.05% of WPG Advisers's portfolio in Q3 2026, its #210 holding.
  • WPG Advisers first reported a position in Jazz Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
  • WPG Advisers's Jazz Pharmaceuticals position peaked at $92.5K in Q2 2026.
  • 331 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.

Based on WPG Advisers's 13F filing for Q3 2026, filed 27 Oct 2026.